Steven Cohen's ABT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.55 M shares of Abbott Laboratories (ABT) worth $140.82 M, representing 0.16% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ABT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.55 M shares. Largest reduction occurred in Q1 2018, reducing 1.79 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.55 M | New Buy | 1.55 M | $90.74 |
| Q1 2024 | -472,163 | Sold Out | 0 | $0.00 |
| Q4 2023 | -184,663 | Reduce 28.11% | 472,163 | $110.07 |
| Q3 2023 | +656,826 | New Buy | 656,826 | $96.85 |
| Q3 2022 | -86,254 | Sold Out | 0 | $0.00 |
| Q2 2022 | +86,254 | New Buy | 86,254 | $108.64 |
| Q4 2021 | -64,300 | Sold Out | 0 | $0.00 |
| Q3 2021 | -4,500 | Reduce 6.54% | 64,300 | $118.13 |
| Q2 2021 | +68,800 | New Buy | 68,800 | $115.93 |
| Q4 2020 | -165,120 | Sold Out | 0 | $0.00 |
| Q3 2020 | +165,120 | New Buy | 165,120 | $108.83 |
| Q2 2019 | -515,235 | Sold Out | 0 | $0.00 |
| Q1 2019 | +151,935 | Add 41.82% | 515,235 | $79.94 |
| Q4 2018 | +352,000 | Add 3115.04% | 363,300 | $72.33 |
| Q3 2018 | +11,300 | New Buy | 11,300 | $73.36 |
| Q2 2018 | -1,100 | Sold Out | 0 | $0.00 |
| Q1 2018 | -1.79 M | Reduce 99.94% | 1,100 | $60.00 |
| Q4 2017 | +894,356 | Add 100.02% | 1.79 M | $57.07 |
| Q3 2017 | +894,179 | New Buy | 894,179 | $53.36 |
| Q4 2016 | -606,700 | Sold Out | 0 | $0.00 |
| Q3 2016 | +606,700 | New Buy | 606,700 | $42.29 |
| Q4 2014 | -200,000 | Sold Out | 0 | $0.00 |
| Q3 2014 | +200,000 | New Buy | 200,000 | $41.59 |
Steven Cohen's Abbott Laboratories Investment FAQs
Steven Cohen first purchased Abbott Laboratories (ABT) in Q3 2014, acquiring 200,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Abbott Laboratories (ABT) for 23 quarters since Q3 2014.
Steven Cohen's largest addition to Abbott Laboratories (ABT) was in Q2 2026, adding 1,551,929 shares worth $140.82 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,551,929 shares of Abbott Laboratories (ABT), valued at approximately $140.82 M.
As of the Q2 2026 filing, Abbott Laboratories (ABT) represents approximately 0.16% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Abbott Laboratories (ABT) was 1,788,535 shares, as reported at the end of Q4 2017.